0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nattokinase Tablets Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-29A15744
Home | Market Reports | Health| Pharmacy
Global Nattokinase Tablets Market Research Report 2023
BUY CHAPTERS

Global Nattokinase Tablets Market Research Report 2025

Code: QYRE-Auto-29A15744
Report
May 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nattokinase Tablets Market

The global market for Nattokinase Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The driving factors for the development of nattokinase tablets mainly include the following points:
Increase in health awareness: People are paying more and more attention to health. Nattokinase, as a natural bioactive substance, has gradually attracted widespread attention for its health-care effects, which has promoted the growth of market demand for nattokinase-related products.
Medical research support: In recent years, more and more medical studies have confirmed the positive role of nattokinase in the prevention and auxiliary treatment of cardiovascular diseases, strokes and other diseases, providing strong scientific basis and support for the promotion of nattokinase products.
Technological progress: With the continuous development of biotechnology, the extraction, purification and production technology of nattokinase are also continuously improved and upgraded, which improves the quality and stability of the product and also reduces the production cost, which provides a good foundation for nattokinase products. It creates conditions for widespread application and popularization.
Market demand: As the global aging trend intensifies, the market demand for chronic diseases such as cardiovascular disease continues to grow. As a natural health product with preventive and therapeutic effects, the market demand for nattokinase is also expanding.
Policy support: Policy support and encouragement for natural medicines and health products in many countries and regions have also promoted the development of the nattokinase industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nattokinase Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nattokinase Tablets.
The Nattokinase Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nattokinase Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nattokinase Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nattokinase Tablets Market Report

Report Metric Details
Report Name Nattokinase Tablets Market
Segment by Type
  • 0-10000Fu/g
  • 10001-20000Fu/g
  • >20001Fu/g
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Biohouse, Daiwa Pharmaceutical, ‎Doctor's Best, Inc, FINE, Beijing Tongrentang, Fairvital, Dykam, Vinsic, Dr.Velor, KOBAYASHI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nattokinase Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nattokinase Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Nattokinase Tablets Market report?

Ans: The main players in the Nattokinase Tablets Market are Biohouse, Daiwa Pharmaceutical, ‎Doctor's Best, Inc, FINE, Beijing Tongrentang, Fairvital, Dykam, Vinsic, Dr.Velor, KOBAYASHI

What are the Application segmentation covered in the Nattokinase Tablets Market report?

Ans: The Applications covered in the Nattokinase Tablets Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Nattokinase Tablets Market report?

Ans: The Types covered in the Nattokinase Tablets Market report are 0-10000Fu/g, 10001-20000Fu/g, >20001Fu/g

Recommended Reports

Cardiovascular Care

Pharmaceutical Ingredients

Herbal Supplementation

1 Nattokinase Tablets Market Overview
1.1 Product Definition
1.2 Nattokinase Tablets by Type
1.2.1 Global Nattokinase Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 0-10000Fu/g
1.2.3 10001-20000Fu/g
1.2.4 >20001Fu/g
1.3 Nattokinase Tablets by Application
1.3.1 Global Nattokinase Tablets Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Nattokinase Tablets Market Size Estimates and Forecasts
1.4.1 Global Nattokinase Tablets Revenue 2020-2031
1.4.2 Global Nattokinase Tablets Sales 2020-2031
1.4.3 Global Nattokinase Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nattokinase Tablets Market Competition by Manufacturers
2.1 Global Nattokinase Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nattokinase Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nattokinase Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nattokinase Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nattokinase Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nattokinase Tablets, Product Type & Application
2.7 Global Key Manufacturers of Nattokinase Tablets, Date of Enter into This Industry
2.8 Global Nattokinase Tablets Market Competitive Situation and Trends
2.8.1 Global Nattokinase Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nattokinase Tablets Players Market Share by Revenue
2.8.3 Global Nattokinase Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nattokinase Tablets Market Scenario by Region
3.1 Global Nattokinase Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nattokinase Tablets Sales by Region: 2020-2031
3.2.1 Global Nattokinase Tablets Sales by Region: 2020-2025
3.2.2 Global Nattokinase Tablets Sales by Region: 2026-2031
3.3 Global Nattokinase Tablets Revenue by Region: 2020-2031
3.3.1 Global Nattokinase Tablets Revenue by Region: 2020-2025
3.3.2 Global Nattokinase Tablets Revenue by Region: 2026-2031
3.4 North America Nattokinase Tablets Market Facts & Figures by Country
3.4.1 North America Nattokinase Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nattokinase Tablets Sales by Country (2020-2031)
3.4.3 North America Nattokinase Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nattokinase Tablets Market Facts & Figures by Country
3.5.1 Europe Nattokinase Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nattokinase Tablets Sales by Country (2020-2031)
3.5.3 Europe Nattokinase Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nattokinase Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Nattokinase Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nattokinase Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Nattokinase Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nattokinase Tablets Market Facts & Figures by Country
3.7.1 Latin America Nattokinase Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nattokinase Tablets Sales by Country (2020-2031)
3.7.3 Latin America Nattokinase Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nattokinase Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Nattokinase Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nattokinase Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nattokinase Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nattokinase Tablets Sales by Type (2020-2031)
4.1.1 Global Nattokinase Tablets Sales by Type (2020-2025)
4.1.2 Global Nattokinase Tablets Sales by Type (2026-2031)
4.1.3 Global Nattokinase Tablets Sales Market Share by Type (2020-2031)
4.2 Global Nattokinase Tablets Revenue by Type (2020-2031)
4.2.1 Global Nattokinase Tablets Revenue by Type (2020-2025)
4.2.2 Global Nattokinase Tablets Revenue by Type (2026-2031)
4.2.3 Global Nattokinase Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Nattokinase Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nattokinase Tablets Sales by Application (2020-2031)
5.1.1 Global Nattokinase Tablets Sales by Application (2020-2025)
5.1.2 Global Nattokinase Tablets Sales by Application (2026-2031)
5.1.3 Global Nattokinase Tablets Sales Market Share by Application (2020-2031)
5.2 Global Nattokinase Tablets Revenue by Application (2020-2031)
5.2.1 Global Nattokinase Tablets Revenue by Application (2020-2025)
5.2.2 Global Nattokinase Tablets Revenue by Application (2026-2031)
5.2.3 Global Nattokinase Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Nattokinase Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biohouse
6.1.1 Biohouse Company Information
6.1.2 Biohouse Description and Business Overview
6.1.3 Biohouse Nattokinase Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biohouse Nattokinase Tablets Product Portfolio
6.1.5 Biohouse Recent Developments/Updates
6.2 Daiwa Pharmaceutical
6.2.1 Daiwa Pharmaceutical Company Information
6.2.2 Daiwa Pharmaceutical Description and Business Overview
6.2.3 Daiwa Pharmaceutical Nattokinase Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Daiwa Pharmaceutical Nattokinase Tablets Product Portfolio
6.2.5 Daiwa Pharmaceutical Recent Developments/Updates
6.3 ‎Doctor's Best, Inc
6.3.1 ‎Doctor's Best, Inc Company Information
6.3.2 ‎Doctor's Best, Inc Description and Business Overview
6.3.3 ‎Doctor's Best, Inc Nattokinase Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ‎Doctor's Best, Inc Nattokinase Tablets Product Portfolio
6.3.5 ‎Doctor's Best, Inc Recent Developments/Updates
6.4 FINE
6.4.1 FINE Company Information
6.4.2 FINE Description and Business Overview
6.4.3 FINE Nattokinase Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 FINE Nattokinase Tablets Product Portfolio
6.4.5 FINE Recent Developments/Updates
6.5 Beijing Tongrentang
6.5.1 Beijing Tongrentang Company Information
6.5.2 Beijing Tongrentang Description and Business Overview
6.5.3 Beijing Tongrentang Nattokinase Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Beijing Tongrentang Nattokinase Tablets Product Portfolio
6.5.5 Beijing Tongrentang Recent Developments/Updates
6.6 Fairvital
6.6.1 Fairvital Company Information
6.6.2 Fairvital Description and Business Overview
6.6.3 Fairvital Nattokinase Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fairvital Nattokinase Tablets Product Portfolio
6.6.5 Fairvital Recent Developments/Updates
6.7 Dykam
6.7.1 Dykam Company Information
6.7.2 Dykam Description and Business Overview
6.7.3 Dykam Nattokinase Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dykam Nattokinase Tablets Product Portfolio
6.7.5 Dykam Recent Developments/Updates
6.8 Vinsic
6.8.1 Vinsic Company Information
6.8.2 Vinsic Description and Business Overview
6.8.3 Vinsic Nattokinase Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vinsic Nattokinase Tablets Product Portfolio
6.8.5 Vinsic Recent Developments/Updates
6.9 Dr.Velor
6.9.1 Dr.Velor Company Information
6.9.2 Dr.Velor Description and Business Overview
6.9.3 Dr.Velor Nattokinase Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Dr.Velor Nattokinase Tablets Product Portfolio
6.9.5 Dr.Velor Recent Developments/Updates
6.10 KOBAYASHI
6.10.1 KOBAYASHI Company Information
6.10.2 KOBAYASHI Description and Business Overview
6.10.3 KOBAYASHI Nattokinase Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 KOBAYASHI Nattokinase Tablets Product Portfolio
6.10.5 KOBAYASHI Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nattokinase Tablets Industry Chain Analysis
7.2 Nattokinase Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nattokinase Tablets Production Mode & Process Analysis
7.4 Nattokinase Tablets Sales and Marketing
7.4.1 Nattokinase Tablets Sales Channels
7.4.2 Nattokinase Tablets Distributors
7.5 Nattokinase Tablets Customer Analysis
8 Nattokinase Tablets Market Dynamics
8.1 Nattokinase Tablets Industry Trends
8.2 Nattokinase Tablets Market Drivers
8.3 Nattokinase Tablets Market Challenges
8.4 Nattokinase Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Nattokinase Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nattokinase Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nattokinase Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nattokinase Tablets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nattokinase Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nattokinase Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nattokinase Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nattokinase Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nattokinase Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nattokinase Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nattokinase Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Nattokinase Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nattokinase Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nattokinase Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nattokinase Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nattokinase Tablets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Nattokinase Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Nattokinase Tablets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Nattokinase Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Nattokinase Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nattokinase Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Nattokinase Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nattokinase Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Nattokinase Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nattokinase Tablets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Nattokinase Tablets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Nattokinase Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nattokinase Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nattokinase Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nattokinase Tablets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Nattokinase Tablets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Nattokinase Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nattokinase Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nattokinase Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nattokinase Tablets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Nattokinase Tablets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Nattokinase Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nattokinase Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nattokinase Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nattokinase Tablets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Nattokinase Tablets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Nattokinase Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nattokinase Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nattokinase Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nattokinase Tablets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Nattokinase Tablets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Nattokinase Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nattokinase Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nattokinase Tablets Sales (K Units) by Type (2020-2025)
 Table 51. Global Nattokinase Tablets Sales (K Units) by Type (2026-2031)
 Table 52. Global Nattokinase Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Nattokinase Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Nattokinase Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nattokinase Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nattokinase Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Nattokinase Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Nattokinase Tablets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Nattokinase Tablets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Nattokinase Tablets Sales (K Units) by Application (2020-2025)
 Table 61. Global Nattokinase Tablets Sales (K Units) by Application (2026-2031)
 Table 62. Global Nattokinase Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Nattokinase Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Nattokinase Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nattokinase Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nattokinase Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Nattokinase Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Nattokinase Tablets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Nattokinase Tablets Price (US$/Unit) by Application (2026-2031)
 Table 70. Biohouse Company Information
 Table 71. Biohouse Description and Business Overview
 Table 72. Biohouse Nattokinase Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Biohouse Nattokinase Tablets Product
 Table 74. Biohouse Recent Developments/Updates
 Table 75. Daiwa Pharmaceutical Company Information
 Table 76. Daiwa Pharmaceutical Description and Business Overview
 Table 77. Daiwa Pharmaceutical Nattokinase Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Daiwa Pharmaceutical Nattokinase Tablets Product
 Table 79. Daiwa Pharmaceutical Recent Developments/Updates
 Table 80. ‎Doctor's Best, Inc Company Information
 Table 81. ‎Doctor's Best, Inc Description and Business Overview
 Table 82. ‎Doctor's Best, Inc Nattokinase Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. ‎Doctor's Best, Inc Nattokinase Tablets Product
 Table 84. ‎Doctor's Best, Inc Recent Developments/Updates
 Table 85. FINE Company Information
 Table 86. FINE Description and Business Overview
 Table 87. FINE Nattokinase Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. FINE Nattokinase Tablets Product
 Table 89. FINE Recent Developments/Updates
 Table 90. Beijing Tongrentang Company Information
 Table 91. Beijing Tongrentang Description and Business Overview
 Table 92. Beijing Tongrentang Nattokinase Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Beijing Tongrentang Nattokinase Tablets Product
 Table 94. Beijing Tongrentang Recent Developments/Updates
 Table 95. Fairvital Company Information
 Table 96. Fairvital Description and Business Overview
 Table 97. Fairvital Nattokinase Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Fairvital Nattokinase Tablets Product
 Table 99. Fairvital Recent Developments/Updates
 Table 100. Dykam Company Information
 Table 101. Dykam Description and Business Overview
 Table 102. Dykam Nattokinase Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Dykam Nattokinase Tablets Product
 Table 104. Dykam Recent Developments/Updates
 Table 105. Vinsic Company Information
 Table 106. Vinsic Description and Business Overview
 Table 107. Vinsic Nattokinase Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Vinsic Nattokinase Tablets Product
 Table 109. Vinsic Recent Developments/Updates
 Table 110. Dr.Velor Company Information
 Table 111. Dr.Velor Description and Business Overview
 Table 112. Dr.Velor Nattokinase Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Dr.Velor Nattokinase Tablets Product
 Table 114. Dr.Velor Recent Developments/Updates
 Table 115. KOBAYASHI Company Information
 Table 116. KOBAYASHI Description and Business Overview
 Table 117. KOBAYASHI Nattokinase Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. KOBAYASHI Nattokinase Tablets Product
 Table 119. KOBAYASHI Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Nattokinase Tablets Distributors List
 Table 123. Nattokinase Tablets Customers List
 Table 124. Nattokinase Tablets Market Trends
 Table 125. Nattokinase Tablets Market Drivers
 Table 126. Nattokinase Tablets Market Challenges
 Table 127. Nattokinase Tablets Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nattokinase Tablets
 Figure 2. Global Nattokinase Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nattokinase Tablets Market Share by Type: 2024 & 2031
 Figure 4. 0-10000Fu/g Product Picture
 Figure 5. 10001-20000Fu/g Product Picture
 Figure 6. >20001Fu/g Product Picture
 Figure 7. Global Nattokinase Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Nattokinase Tablets Market Share by Application: 2024 & 2031
 Figure 9. Online Sales
 Figure 10. Offline Sales
 Figure 11. Global Nattokinase Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Nattokinase Tablets Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Nattokinase Tablets Sales (2020-2031) & (K Units)
 Figure 14. Global Nattokinase Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 15. Nattokinase Tablets Report Years Considered
 Figure 16. Nattokinase Tablets Sales Share by Manufacturers in 2024
 Figure 17. Global Nattokinase Tablets Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Nattokinase Tablets Players: Market Share by Revenue in Nattokinase Tablets in 2024
 Figure 19. Nattokinase Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Nattokinase Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Nattokinase Tablets Sales Market Share by Country (2020-2031)
 Figure 22. North America Nattokinase Tablets Revenue Market Share by Country (2020-2031)
 Figure 23. United States Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Nattokinase Tablets Sales Market Share by Country (2020-2031)
 Figure 26. Europe Nattokinase Tablets Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Nattokinase Tablets Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Nattokinase Tablets Revenue Market Share by Region (2020-2031)
 Figure 34. China Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Nattokinase Tablets Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Nattokinase Tablets Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Nattokinase Tablets Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Nattokinase Tablets Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Nattokinase Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Nattokinase Tablets by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Nattokinase Tablets by Type (2020-2031)
 Figure 53. Global Nattokinase Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Nattokinase Tablets by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Nattokinase Tablets by Application (2020-2031)
 Figure 56. Global Nattokinase Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 57. Nattokinase Tablets Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart